THE LONG-TERM EFFECT OF CYPROTERONE-ACETATE ON GROWTH IN GIRLS WITH IDIOPATHIC PRECOCIOUS PUBERTY

被引:5
作者
KATO, K
FUJIMOTO, M
HIBI, I
SUWA, S
SHIMIZU, N
机构
[1] ST MARIANNA MED UNIV, SCH MED, DEPT PAEDIAT, KAWASAKI, KANAGAWA 213, JAPAN
[2] NATL CHILDRENS HOSP, DIV ENDOCRINOL & METAB, TOKYO 154, JAPAN
[3] KANAGAWA CHILDRENS MED CTR, DEPT PAEDIAT, YOKOHAMA, KANAGAWA, JAPAN
[4] TEIKYO UNIV, SCH MED, DEPT INTERNAL MED 3, ICHIHARA, JAPAN
关键词
IDIOPATHIC PRECOCIOUS PUBERTY; CYPROTERONE ACETATE; GROWTH PROGNOSIS; DAILY DOSE;
D O I
10.1007/BF01956737
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To define the effect of cyproterone acetate (CPA) on statural growth, 25 girls with idiopathic precocious puberty who had been treated with CPA were studied retrospectively. The final height SDS was -1.12 +/-1.16 (mean +/- SD). The daily CPA dose was negatively related to the final height SDS. We divided our subjects into two groups according to the daily CPA dose [low dose, 84.9 +/- 15.4 Mg/M2 (n = 19) vs high dose, 135.8 +/-17.1 Mg/M2 (n = 6)]. In the low dose group, the difference of the final height SDS minus height SDS for bone age at the initiation of CPA treatment was 0.55 +/- 1.16 and final height SDS was -0.82 +/- 1.05. The final height was not significantly different from the target height in the low dose group subjects whose target heights were obtained. Since the increment of height age to the increment of bone age during the treatment was significantly less in the group needing and treated with high dose CPA, high doses of CPA may reduce growth velocity more than its suppressive effect on bone maturation. These results suggest that CPA has an effect on statural growth in girls whose clinical symptoms can be controlled with a low dose of CPA, although they have not been compared with final height in untreated Japanese girls.
引用
收藏
页码:297 / 300
页数:4
相关论文
共 20 条
[1]  
ABE K, 1982, ENDOCRINOL JAPON, V29, P27
[2]   SHORT-TERM TREATMENT OF IDIOPATHIC PRECOCIOUS PUBERTY WITH A LONG-ACTING ANALOG OF LUTEINIZING-HORMONE-RELEASING HORMONE - A PRELIMINARY-REPORT [J].
COMITE, F ;
CUTLER, GB ;
RIVIER, J ;
VALE, WW ;
LORIAUX, DL ;
CROWLEY, WF .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (26) :1546-1550
[3]   THERAPEUTIC USE OF PITUITARY DESENSITIZATION WITH A LONG-ACTING LHRH AGONIST - A POTENTIAL NEW TREATMENT FOR IDIOPATHIC PRECOCIOUS PUBERTY [J].
CROWLEY, WF ;
COMITE, F ;
VALE, W ;
RIVIER, J ;
LORIAUX, DL ;
CUTLER, GB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 52 (02) :370-372
[4]  
FREULICH WW, 1959, RADIOGRAPHIC ATLAS S
[5]  
FUJIMOTO M, 1989, CLIN ENDOCRINOL, V37, P519
[6]   CYPROTERONEACETATE AND ACTH ADRENAL-FUNCTION [J].
GIRARD, J ;
BAUMANN, JB ;
BUHLER, U ;
ZUPPINGER, K ;
HAAS, HG ;
STAUB, JJ ;
WYSS, HI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1978, 47 (03) :581-586
[7]   EFFECT OF CYPROTERONE-ACETATE ON ADRENAL-CORTICAL FUNCTION IN CHILDREN WITH PRECOCIOUS PUBERTY [J].
HEINZE, F ;
TELLER, WM ;
FEHM, HL ;
JOOS, A .
EUROPEAN JOURNAL OF PEDIATRICS, 1978, 128 (02) :81-88
[8]  
KATO K, 1988, PROGR ENDOCRINOLOGY, P145
[9]   CYPROTERONE-ACETATE IN TREATMENT OF PRECOCIOUS PUBERTY [J].
KAULI, R ;
PERTZELAN, A ;
PRAGERLEWIN, R ;
GRUNEBAUM, M ;
LARON, Z .
ARCHIVES OF DISEASE IN CHILDHOOD, 1976, 51 (03) :202-208
[10]  
KAULI R, 1980, HELV PAEDIATR ACTA, V35, P149